EUVIMEDEUVIMED entdecken
Open Access

Protection Against Type 1 Diabetes Development in Mice With 4E-BP2 Deletion

Valentina Pita-Grisanti iD, Flavia Leticia Martins Peçanha, Ruy A Louzada, Manuel Blandino-Rosano, Camillo Jaramillo, Natalia Arenas, Allison Bayer iD, Ernesto Bernal-Mizrachi iD

Diabetes · 2026

DOI: 10.2337/db25-0348 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes, 2026. Verfasst von Valentina Pita-Grisanti und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, University of Miami Miller School of Medicine, Miami, FL. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1, Eukaryotic Initiation Factors, Insulin-Secreting Cells. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, BLRD VA, NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Type 1 diabetes (T1D) is an autoimmune disease characterized by β-cell destruction promoted by autoreactive T cells. Eukaryotic translation initiation factor 4E (eIF4E)–binding protein 1 (4E-BP1) and 4E-BP2 are translational repressors and downstream targets of mammalian target of rapamycin complex 1 (mTORC1). Activation of the 4E-BP2/eIF4E pathway by 4E-BP2 deletion promotes translation initiation, inducing β-cell expansion and proliferation and regulating adaptive immunity. However, the involvement of 4E-BP2 in T1D remains unexplored. This study aimed to determine the role of 4E-BP2/eIF4E signaling in T1D prevention. We used the NOD mouse model of T1D and generated mice with global 4E-BP2 deletion in the NOD background (Eif4ebp2−/−). We assessed T1D development, glucose homeostasis, pancreas morphometry, and immune responses in Eif4ebp2−/− and littermate control mice. We found that Eif4ebp2−/− male mice exhibited reduced diabetes incidence, which did not occur in female mice, as well as preserved β-cell mass, improved insulin secretion in vitro, and comparable insulitis. Characterization of T-cell compartments showed decreased splenic CD8+ cytotoxic T-cell proliferation and increased pancreatic regulatory T-cell infiltration in Eif4ebp2−/− mice, potentially resulting from increased proliferation and suppressive capacity. Adoptive transfer studies demonstrated that Eif4ebp2−/− male lymphocytes were less diabetogenic than those of controls. In conclusion, activation of 4E-BP2/eIF4E by 4E-BP2 deletion protected against T1D, supporting 4E-BP2 as a potential therapy target. Article Highlights Mammalian target of rapamycin complex 1 (mTORC1) signaling is essential to β-cell mass, function, and adaptive immunity; however, its specific downstream mediators in type 1 diabetes (T1D) remain poorly defined. We investigated eukaryotic translation initiation factor 4E–binding protein 2 (4E-BP2), a major translational regulator downstream of mTORC1, by using global 4E-BP2–knockout mice on the NOD background. Loss of 4E-BP2 protected male NOD mice from T1D through preservation of β-cell mass and function, coupled with attenuation of autoimmune responses. These findings identify 4E-BP2 as a novel immunometabolic node, highlighting its potential as a therapeutic target for T1D prevention and treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 1Eukaryotic Initiation FactorsInsulin-Secreting CellsAnimalsMiceMice, KnockoutMice, Inbred NODMaleMechanistic Target of Rapamycin Complex 1TOR Serine-Threonine Kinases

Substanzen

Eif4ebp2 protein, mouseEukaryotic Initiation FactorsMechanistic Target of Rapamycin Complex 1TOR Serine-Threonine Kinases

Autor:innen und Institutionen

  • Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, University of Miami Miller School of Medicine, Miami, FL.
  • Department of Microbiology and Immunology, University of Miami Miller School of Medicine, Miami, FL.
  • Department of Pathology, Immunology and Laboratory Medicine and Diabetes Institute, University of Florida College of Medicine, Gainesville, FL.
  • Diabetes Research Institute, University of Miami Miller School of Medicine, Miami, FL.
  • Geriatric Research, Education, and Clinical Center and Research Service, Veterans Affairs Medical Center, Miami, FL.

ORCID-Profile: Valentina Pita-Grisanti, Allison Bayer, Ernesto Bernal-Mizrachi

Förderung

  • NIDDK NIH HHS
  • BLRD VA
  • NCI NIH HHS
  • Division of Diabetes, Endocrinology, and Metabolic Diseases
  • U.S. Department of Veterans Affairs

Zitieren

APA

Pita-Grisanti, V., Peçanha, F. L. M., Louzada, R. A., Blandino-Rosano, M., Jaramillo, C., Arenas, N., Bayer, A., & Bernal-Mizrachi, E. (2026). Protection Against Type 1 Diabetes Development in Mice With 4E-BP2 Deletion. Diabetes. https://doi.org/10.2337/db25-0348

Vancouver

Pita-Grisanti V, Peçanha FLM, Louzada RA, Blandino-Rosano M, Jaramillo C, Arenas N, et al. Protection Against Type 1 Diabetes Development in Mice With 4E-BP2 Deletion. Diabetes. 2026. doi:10.2337/db25-0348

BibTeX
@article{PitaGrisanti2026,
  author = {Pita-Grisanti, Valentina and Peçanha, Flavia Leticia Martins and Louzada, Ruy A and Blandino-Rosano, Manuel and Jaramillo, Camillo and Arenas, Natalia and Bayer, Allison and Bernal-Mizrachi, Ernesto},
  title = {Protection Against Type 1 Diabetes Development in Mice With 4E-BP2 Deletion},
  journal = {Diabetes},
  year = {2026},
  doi = {10.2337/db25-0348}
}
Kostenlos starten →